Studienserver - Medizinische Hochschule Hannover

Studien: IMA901 in patients receiving sunitinib for advanced/metastatic RCC

ID Studie

IMA901-301

EudraCT-Nummer

2010-022459-45

Clinicaltrials.gov Identifier

NCT01265901

Beschreibung

A randomized, controlled Phase III study investigating IMA901 multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic renal cell carcinoma

Status

beendet